Oppenheimer Stock Ratings and Recommendations (NYSE:OPY)

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Oppenheimer. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Oppenheimer.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
7/16/2018OppenheimerSet Price TargetSpero Therapeutics (SPRO)Buy $30.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/16/2018OppenheimerReiteratesEncore Capital Group (ECPG)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
7/17/2018OppenheimerRaises TargetVisa (V)Outperform$143.00 -> $154.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/17/2018OppenheimerRaises TargetMastercard (MA)Outperform$197.00 -> $215.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/16/2018OppenheimerRaises TargetCitigroup (C)Outperform -> Outperformer$89.00 -> $91.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/13/2018OppenheimerSet Price TargetMotus GI (MOTS)Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/12/2018OppenheimerInitiatesADMA Biologics (ADMA)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/12/2018OppenheimerInitiatesAvenue Therapeutics (ATXI)Buy $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/12/2018OppenheimerInitiatesCatalyst Pharmaceuticals (CPRX)Buy $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/12/2018OppenheimerInitiatesAcelRx Pharmaceuticals (ACRX)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
7/11/2018OppenheimerRaises Targetsalesforce.com (CRM)Outperform$152.00 -> $160.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/10/2018OppenheimerSet Price TargetITT (ITT)Buy $60.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018OppenheimerReiteratesAxovant Sciences (AXON)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
7/10/2018OppenheimerSet Price TargetKKR & Co. L.P. Unit (KKR)Buy $29.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/10/2018OppenheimerInitiatesSpotify (SPOT)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
7/10/2018OppenheimerDowngradesSquare (SQ)Outperform -> Market PerformMediumView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018OppenheimerRaises TargetMirati Therapeutics (MRTX)Outperform$35.00 -> $62.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018OppenheimerRaises TargetKura Oncology (KURA)Outperform$27.00 -> $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018OppenheimerRaises TargetLululemon Athletica (LULU)Outperform$125.00 -> $140.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018OppenheimerSet Price TargetSpero Therapeutics (SPRO)Buy $30.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/8/2018OppenheimerSet Price TargetBiogen (BIIB)Buy$375.00 -> $400.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018OppenheimerUpgradesCapital One Financial (COF)Market Perform -> Outperform $113.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/5/2018OppenheimerInitiatesValeritas (VLRX)Outperform $3.50HighView Rating Details  Share on Twitter  Share on StockTwits
7/3/2018OppenheimerUpgradesRoku (ROKU)Market Perform -> Outperform $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/1/2018OppenheimerReiteratesCarlisle Companies (CSL)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
6/29/2018OppenheimerInitiatesSynlogic (SYBX)Outperform $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/29/2018OppenheimerInitiatesAlpine Immune Sciences (ALPN)Outperform $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/27/2018OppenheimerUpgradesRegeneron Pharmaceuticals (REGN)Market Perform -> Outperform $325.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/27/2018OppenheimerUpgradesGeneral Electric (GE)Underperform -> Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
6/26/2018OppenheimerRaises TargetDarden Restaurants (DRI)Outperform -> Outperform$105.00 -> $115.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/22/2018OppenheimerRaises TargetRexnord (RXN)Outperform -> Outperform$33.00 -> $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/22/2018OppenheimerRaises TargetHeron Therapeutics (HRTX)Outperform -> Outperform$34.00 -> $50.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/22/2018OppenheimerInitiatesAlteryx (AYX)Outperform $48.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/22/2018OppenheimerRaises TargetTrade Desk (TTD)Outperform $101.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/21/2018OppenheimerReiteratesTesla (TSLA)NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
6/21/2018OppenheimerRaises TargetSemtech (SMTC)Outperform -> Outperform$50.00 -> $58.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/19/2018OppenheimerRaises TargetRingCentral (RNG)Outperform -> Outperform$79.00 -> $92.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/19/2018OppenheimerRaises Targetathenahealth (ATHN)Outperform -> Outperform$158.00 -> $179.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/18/2018OppenheimerRaises TargetCentene (CNC)$130.00 -> $138.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/18/2018OppenheimerRaises TargetImperva (IMPV)Outperform$55.00 -> $60.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/18/2018OppenheimerInitiatesEvofem Biosciences (EVFM)Outperform $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/14/2018OppenheimerInitiatesDelphi Technologies (DLPH)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
6/14/2018OppenheimerReiteratesNetflix (NFLX)Buy $370.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/14/2018OppenheimerRaises TargetFedEx (FDX)Outperform$282.00 -> $288.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/14/2018OppenheimerRaises TargetGrubHub (GRUB)Outperform$100.00 -> $130.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/13/2018OppenheimerUpgradesAT&T (T)Market Perform -> Outperform $41.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/12/2018OppenheimerReiteratesAxovant Sciences (AXON)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
6/12/2018OppenheimerRaises TargetCellectis (CLLS)Outperform -> Outperform$40.00 -> $44.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/12/2018OppenheimerRaises Targetathenahealth (ATHN)Outperform -> Outperform$158.00 -> $179.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/12/2018OppenheimerInitiatesArQule (ARQL)Outperform $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018OppenheimerSet Price TargetMediwound (MDWD)Buy $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018OppenheimerRaises TargetCogent Communications (CCOI)Outperform$51.00 -> $57.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018OppenheimerRaises TargetMonolithic Power Systems (MPWR)Outperform$130.00 -> $150.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018OppenheimerSet Price TargetAcorda Therapeutics (ACOR)Hold $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/8/2018OppenheimerSet Price TargetCooper Companies (COO)Hold $265.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/8/2018OppenheimerRaises TargetWayfair (W)Outperform $120.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/7/2018OppenheimerInitiatesEnanta Pharmaceuticals (ENTA)Buy $135.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/7/2018OppenheimerRaises TargetSPS Commerce (SPSC)Outperform -> Outperform$72.00 -> $83.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/7/2018OppenheimerRaises TargetOkta (OKTA)Outperform -> Outperform$51.00 -> $60.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/6/2018OppenheimerReiteratesAxovant Sciences (AXON)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
6/6/2018OppenheimerReiteratesAmbarella (AMBA)Outperform -> Market PerformMediumView Rating Details  Share on Twitter  Share on StockTwits
6/6/2018OppenheimerRaises TargetWix.Com (WIX)Outperform$90.00 -> $105.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/6/2018OppenheimerSet Price TargetMedtronic (MDT)Buy $96.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/6/2018OppenheimerReiteratesPra Group (PRAA)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
6/5/2018OppenheimerSet Price TargetTherapeuticsMD (TXMD)Buy $12.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/5/2018OppenheimerSet Price TargetPortola Pharmaceuticals (PTLA)Buy $80.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/5/2018OppenheimerInitiatesCision (CISN)Outperform $19.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/5/2018OppenheimerLowers TargetDollar Tree (DLTR)Outperform$108.00 -> $92.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/5/2018OppenheimerRaises TargetHealthequity (HQY)Outperform$68.00 -> $85.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/4/2018OppenheimerLowers TargetWyndham Destinations (WYND)Outperform$135.00 -> $66.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/4/2018OppenheimerInitiatesWyndham Hotels & Resorts (WH)Outperform $69.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/1/2018OppenheimerSet Price TargetIntegra Lifesciences (IART)Buy $74.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/1/2018OppenheimerSet Price TargetIncyte (INCY)Hold $65.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/1/2018OppenheimerReiteratesAmazon.com (AMZN)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
6/1/2018OppenheimerReiteratesMicrosoft (MSFT)Buy $115.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/1/2018OppenheimerRaises TargetTiffany & Co. (TIF)Outperform $145.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/31/2018OppenheimerUpgradesMadrigal Pharmaceuticals (MDGL)Market Perform -> Outperform $300.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/31/2018OppenheimerRaises TargetPalo Alto Networks (PANW)Outperform$235.00 -> $200.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/31/2018OppenheimerRaises TargetCoupa Software (COUP)Outperform$55.00 -> $62.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/30/2018OppenheimerRaises TargetAnalog Devices (ADI)Outperform$100.00 -> $110.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/30/2018OppenheimerSet Price TargetTherapeuticsMD (TXMD)Buy $12.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/30/2018OppenheimerRaises Targetsalesforce.com (CRM)Outperform$135.00 -> $152.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/29/2018OppenheimerRaises TargetLululemon Athletica (LULU)Outperform$90.00 -> $115.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/27/2018OppenheimerSet Price TargetTandem Diabetes Care (TNDM)Buy $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/25/2018OppenheimerReiteratesProthena (PRTA)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/25/2018OppenheimerRaises TargetPaypal (PYPL)Outperform$85.00 -> $90.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018OppenheimerSet Price TargetIntec Pharma (NTEC)Buy $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/25/2018OppenheimerSet Price TargetRecro Pharma (REPH)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018OppenheimerInitiatesVistagen Therapeutics (VTGN)Buy $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018OppenheimerInitiatesEnanta Pharmaceuticals (ENTA)Buy $135.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018OppenheimerReiteratesMedtronic (MDT)Buy $96.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018OppenheimerRaises TargetSemtech (SMTC)Outperform -> Outperform$42.00 -> $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018OppenheimerRaises TargetOkta (OKTA)Outperform -> Outperform$43.00 -> $51.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018OppenheimerLowers TargetNCR (NCR)Outperform -> Outperform$51.00 -> $37.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018OppenheimerInitiatese.l.f. Beauty (ELF)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
5/23/2018OppenheimerReiteratesNetApp (NTAP)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
5/23/2018OppenheimerSet Price TargetSpero Therapeutics (SPRO)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/23/2018OppenheimerRaises TargetIntuit (INTU)Outperform$181.00 -> $206.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/23/2018OppenheimerRaises TargetVaronis Systems (VRNS)Outperform$71.00 -> $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/22/2018OppenheimerSet Price TargetHewlett Packard Enterprise (HPE)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/23/2018OppenheimerRaises TargetCtrip.Com International (CTRP)Outperform$51.00 -> $54.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/22/2018OppenheimerRaises TargetVMware (VMW)Outperform -> Outperform$135.00 -> $165.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/22/2018OppenheimerRaises TargetThe Ensign Group (ENSG)Outperform -> Outperform$31.00 -> $39.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/22/2018OppenheimerSet Price TargetUrogen Pharma (URGN)Buy $75.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/21/2018OppenheimerSet Price TargetTandem Diabetes Care (TNDM)Buy$10.00 -> $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/17/2018OppenheimerSet Price TargetPortola Pharmaceuticals (PTLA)Buy $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/18/2018OppenheimerLowers TargetSpectrum Brands, Inc. Common Stock (SPB)Outperform$130.00 -> $105.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/17/2018OppenheimerSet Price TargetEiger Biopharmaceuticals (EIGR)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/17/2018OppenheimerReiteratesPacira Pharmaceuticals (PCRX)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018OppenheimerSet Price TargetEncore Capital Group (ECPG)Buy $55.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/15/2018OppenheimerReiteratesMallinckrodt (MNK)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/15/2018OppenheimerSet Price TargetUrogen Pharma (URGN)Buy $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018OppenheimerSet Price TargetKKR & Co. L.P. Unit (KKR)Buy $29.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/15/2018OppenheimerRaises TargetNutanix (NTNX)Outperform$65.00 -> $70.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/15/2018OppenheimerUpgradesUlta Beauty (ULTA)Market Perform -> OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
5/13/2018OppenheimerSet Price TargetSpero Therapeutics (SPRO)Buy $30.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/13/2018OppenheimerReiteratesEndo International (ENDP)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/13/2018OppenheimerReiteratesSynergy Pharmaceuticals (SGYP)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/14/2018OppenheimerSet Price TargetNeurocrine Biosciences (NBIX)Buy $120.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/14/2018OppenheimerUpgradesChildrens Place (PLCE)Market Perform -> OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
5/11/2018OppenheimerSet Price TargetEiger Biopharmaceuticals (EIGR)Buy $26.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/11/2018OppenheimerSet Price TargetPerrigo (PRGO)Buy $98.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/11/2018OppenheimerReiteratesSymantec (SYMC)Outperform -> Market Perform $33.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerSet Price TargetKemPharm (KMPH)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerSet Price TargetHeron Therapeutics (HRTX)Buy $34.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerSet Price TargetMediwound (MDWD)Buy $14.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerRaises TargetSolaredge Technologies (SEDG)Outperform$50.00 -> $64.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerRaises TargetTurtle Beach (HEAR)Outperform$4.00 -> $12.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerRaises TargetRingCentral (RNG)Outperform$66.00 -> $79.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerRaises TargetWix.Com (WIX)Outperform$82.00 -> $90.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerReiteratesAmerica First Multifamily Investors (ATAX)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerSet Price TargetEncore Capital Group (ECPG)Buy $55.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerReiteratesProthena (PRTA)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerReiteratesPra Group (PRAA)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerSet Price TargetWright Medical Group (WMGI)Hold $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerInitiatesTrade Desk (TTD)Outperform $66.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerSet Price TargetVector Group (VGR)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerReiteratesInsys Therapeutics (INSY)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerReiteratesIngevity (NGVT)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerReiteratesLannett (LCI)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerRaises TargetNew Relic (NEWR)Outperform$85.00 -> $90.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerRaises TargetGodaddy (GDDY)Outperform$70.00 -> $80.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerRaises TargetFidelity National Information Servcs (FIS)Outperform$105.00 -> $118.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerRaises TargetElectronic Arts (EA)Outperform$130.00 -> $140.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerRaises TargetTwilio (TWLO)Outperform$45.00 -> $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerReiteratesIntercept Pharmaceuticals (ICPT)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerSet Price TargetMadrigal Pharmaceuticals (MDGL)Hold $130.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerReiteratesMatson (MATX)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerSet Price TargetCymaBay Therapeutics (CBAY)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerSet Price TargetCaesars Entertainment Co. Common Stock (CZR)Buy $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerReiteratesEnPro Industries (NPO)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerSet Price TargetForterra (FRTA)Buy $13.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerReiteratesAllot Communications (ALLT)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerReiteratesZynerba Pharmaceuticals (ZYNE)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerReiteratesFerroglobe (GSM)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerLowers TargetGlobal Blood Therapeutics (GBT)Outperform -> Outperform$79.00 -> $74.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerRaises TargetCarbonite (CARB)Outperform -> Outperform$30.00 -> $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018OppenheimerSet Price TargetAres Management LP Unit (ARES)Buy $30.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018OppenheimerReiteratesCeragon Networks (CRNT)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018OppenheimerReiteratesTeva Pharmaceutical Industries (TEVA)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018OppenheimerRaises TargetAlibaba Group (BABA)Outperform$220.00 -> $230.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/6/2018OppenheimerSet Price TargetCredit Acceptance (CACC)Buy $365.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/6/2018OppenheimerSet Price TargetPortola Pharmaceuticals (PTLA)Buy$67.00 -> $80.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018OppenheimerReiteratesAmazon.com (AMZN)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018OppenheimerReiteratesITT (ITT)Buy $60.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018OppenheimerSet Price TargetSTONECASTLE Fin/COM (BANX)Buy $24.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetVanda Pharmaceuticals (VNDA)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetTherapeuticsMD (TXMD)Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetSpero Therapeutics (SPRO)Buy $30.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetTrevena (TRVN)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018OppenheimerSet Price TargetInsulet (PODD)Hold $90.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018OppenheimerRaises TargetTiffany & Co. (TIF)Outperform$105.00 -> $115.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018OppenheimerDowngradesSarepta Therapeutics (SRPT)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetAres Capital (ARCC)Buy $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerReiteratesWatts Water Technologies (WTS)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetEndologix (ELGX)Hold $5.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetGlobus Medical (GMED)Hold $52.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerReiteratesApollo Global Management LLC Class A (APO)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerSet Price TargetAcorda Therapeutics (ACOR)Hold $21.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerSet Price TargetMatson (MATX)Buy $52.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerSet Price TargetCaesars Entertainment Co. Common Stock (CZR)Buy $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetEnPro Industries (NPO)Buy $100.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetConforMIS (CFMS)Buy $4.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetConatus Pharmaceuticals (CNAT)Buy $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerReiteratesRepublic Services (RSG)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetIngevity (NGVT)Buy $90.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerReiteratesKKR & Co. L.P. Unit (KKR)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerReiteratesColfax (CFX)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerRaises TargetHumana (HUM)Outperform$305.00 -> $311.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerRaises TargetDexcom (DXCM)Outperform$80.00 -> $85.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerRaises TargetBooking (BKNG)Outperform$2,275.00 -> $2,500.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerInitiatesnVent Electric (NVT)Market PerformN/AView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerDowngradesSnap (SNAP)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerRaises TargetSabre (SABR)Outperform -> Outperform$26.00 -> $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerRaises TargetEnphase Energy (ENPH)Outperform -> Outperform$4.00 -> $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerRaises TargetAmeresco (AMRC)Outperform -> Outperform$11.00 -> $13.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerLowers TargetCummins (CMI)Outperform -> Outperform$207.00 -> $192.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerRaises TargetServicemaster Global (SERV)Outperform -> Outperform$55.00 -> $62.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerReiteratesSnap (SNAP)Outperform -> Market Perform $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018OppenheimerSet Price TargetIncyte (INCY)Hold $65.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018OppenheimerSet Price TargetNCR (NCR)Buy $51.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018OppenheimerSet Price TargetIntegra Lifesciences (IART)Buy $70.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerSet Price TargetK2M Group (KTWO)Buy $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018OppenheimerSet Price TargetServicemaster Global (SERV)Buy $55.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018OppenheimerSet Price TargetThe Carlyle Group (CG)Buy $33.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018OppenheimerReiteratesXylem (XYL)Buy $82.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018OppenheimerInitiatesAres Management LP Unit (ARES)Outperform $30.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018OppenheimerLowers TargetHoneywell (HON)Outperform$180.00 -> $172.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018OppenheimerRaises TargetTapestry (TPR)$60.00 -> $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018OppenheimerRaises TargetT-Mobile Us (TMUS)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
4/27/2018OppenheimerReiteratesStarbucks (SBUX)OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
4/27/2018OppenheimerRaises TargetAmazon.com (AMZN)Outperform$1,650.00 -> $1,850.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/27/2018OppenheimerUpgradesTractor Supply (TSCO)Market Perform -> Outperform $80.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018OppenheimerReiteratesIntegra Lifesciences (IART)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018OppenheimerLowers TargetHubbell (HUBB)Outperform$160.00 -> $140.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018OppenheimerReiteratesCapital One Financial (COF)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018OppenheimerSet Price TargetBiogen (BIIB)Buy $375.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018OppenheimerSet Price TargetSix Flags Entertainment (SIX)Buy $80.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018OppenheimerUpgradesCree (CREE)Market Perform -> Outperform $53.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018OppenheimerRaises TargetAlphabet Inc Class C (GOOG)Outperform$1,340.00 -> $1,350.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/23/2018OppenheimerSet Price TargetSLM (SLM)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/23/2018OppenheimerDowngradesProthena (PRTA)Outperform -> HoldHighView Rating Details  Share on Twitter  Share on StockTwits
4/23/2018OppenheimerSet Price TargetIncyte (INCY)Hold $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/22/2018OppenheimerReiteratesSynchrony Financial (SYF)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
4/20/2018OppenheimerUpgradesAlliance Data Systems (ADS)Underperform -> Market Perform $227.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/19/2018OppenheimerRaises TargetAutodesk (ADSK)Outperform$145.00 -> $150.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/19/2018OppenheimerRaises TargetMastercard (MA)Outperform$182.00 -> $187.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/19/2018OppenheimerInitiates8X8 (EGHT)Outperform $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/18/2018OppenheimerRaises TargetGoldman Sachs Group (GS)Outperform$280.00 -> $308.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/18/2018OppenheimerRaises TargetUnitedHealth Group (UNH)Outperform$260.00 -> $276.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/18/2018OppenheimerRaises TargetXPO Logistics (XPO)Outperform$104.00 -> $119.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018OppenheimerRaises TargetDomino's Pizza (DPZ)Outperform$240.00 -> $245.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018OppenheimerRaises TargetNetflix (NFLX)Outperform$285.00 -> $370.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018OppenheimerSet Price TargetCymaBay Therapeutics (CBAY)Buy $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/16/2018OppenheimerInitiatesLimelight Networks (LLNW)Outperform $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/16/2018OppenheimerInitiatesMadrigal Pharmaceuticals (MDGL)Hold $130.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018OppenheimerSet Price TargetCredit Acceptance (CACC)Buy $365.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018OppenheimerSet Price TargetAlliance Data Systems (ADS)Sell $206.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018OppenheimerSet Price TargetAmerican Express (AXP)Buy $110.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018OppenheimerSet Price TargetDiscover Financial Services (DFS)Buy $82.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018OppenheimerSet Price TargetAlly Financial (ALLY)Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018OppenheimerSet Price TargetSLM (SLM)Buy $16.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018OppenheimerRaises TargetEstee Lauder Companies (EL)Outperform$148.00 -> $170.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/11/2018OppenheimerSet Price TargetIntec Pharma (NTEC)Buy $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/11/2018OppenheimerSet Price TargetCymaBay Therapeutics (CBAY)Buy $18.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/10/2018OppenheimerSet Price TargetNeurocrine Biosciences (NBIX)Buy $110.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/9/2018OppenheimerSet Price TargetIncyte (INCY)Hold$110.00 -> $65.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/6/2018OppenheimerReiteratesOrmat Technologies (ORA)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
4/6/2018OppenheimerUpgradesUniversal Display (OLED)Market Perform -> Outperform $120.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/5/2018OppenheimerReiteratesNetApp (NTAP)HoldLowView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Tuesday at 07:23 PM ET.

MarketBeat Community Rating for Oppenheimer

Community Ranking:  1.9 out of 5 (star star star star)
Outperform Votes:  95 (Vote Outperform)
Underperform Votes:  150 (Vote Underperform)
Total Votes:  245
MarketBeat's community ratings are surveys of what our community members think about Oppenheimer and other research firms. Vote "Outperform" if you believe Oppenheimer's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Oppenheimer's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.